• Publications
  • Influence
PHARMACOKINETIC EVALUATION OF OPTIMIZED VALSARTAN TABLETS FORMULATED EMPLOYING β CD, CROSPOVIDONE AND SLS IN COMPARISON TO A MARKET PRODUCT
Valsartan, a widely prescribed anti hypertensive drug belongs to class II under BCS classification and exhibit low and variable oral bioavailability due to its poor aqueous solubility. It needsExpand
EMERGING TECHNOLOGIES AND ADVANCES OF MUCO ADHESIVE DRUG DELIVARY SYSTEMS: AN REVIEW
The aim of this study was to review the mechanisms and theories involved in mucoadhesion. However this route could become a significant means for the delivery of a range of active agents in theExpand
FACTORIAL DESIGN, IN VITRO AND PHARMACOKINETIC EVALUATION
Valsartan, a widely prescribed anti hypertensive drug belongs to class II under BCS classification and needs enhancement in the dissolution rate in its formulation development. The objective of theExpand
EFFECTIVE NOVEL PHARMACEUTICAL TECHNOLOGIES FOR BRAIN DRUG DELIVERY SYSTEMS: AN REVIEW
The regulated entry of most blood-borne substances into the brain has been recognized for more than a century. The blood-brain barrier shielding function provided by endothelial cells is important inExpand
FACTORIAL DESIGN EMPLOYING β CD, CROSPOVIDONE AND SLS
Irbesartan, a widely prescribed anti hypertensive drug belongs to class II under BCS classification and exhibit low and variable oral bioavailability due to its poor aqueous solubility. Because ofExpand
FORMULATION DEVELOPMENT OF VALSARTAN TABLETS EMPLOYING β CD , CROSPOVIDONE AND SLS : OPTIMIZATION BY 2 3 FACTORIAL DESIGN
Valsartan, a widely prescribed anti hypertensive drug belongs to class II under BCS classification and exhibit low and variable oral bioavailability due to its poor aqueous solubility. Because ofExpand
  • 1
  • PDF